How many shares of TAK does BNP PARIBAS FINANCIAL MARKETS own?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS holds 714,143 shares of TAK (TAKEDA PHARMACEUTIC-SP ADR).

What is BNP PARIBAS FINANCIAL MARKETS's TAK position worth?

As of 2026-Q2, BNP PARIBAS FINANCIAL MARKETS's TAK position is worth $11.4M.

Is BNP PARIBAS FINANCIAL MARKETS buying or selling TAK?

In 2026-Q2, BNP PARIBAS FINANCIAL MARKETS increased their TAK position (+275.1% change in shares).

When did BNP PARIBAS FINANCIAL MARKETS first buy TAK?

Based on available 13F filings, BNP PARIBAS FINANCIAL MARKETS first reported a position in TAK in 2019-Q2. They have held the position across 29 quarters.

Back to

BNP PARIBAS FINANCIAL MARKETS

TAK
29 quarters

Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in TAKEDA PHARMACEUTIC-SP ADR

Current Value

$11.4M

Current Shares

714,143

Total Value Change

+$5.8M

Total Shares Change

+393,458

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	714,143	+275.1%	$11.4M	0.0%	$16.03	45
2026-Q1	Increased	190,413	+2.6%	$3.5M	0.0%	$18.08	27
2025-Q4	Increased	185,549	+1557.6%	$2.9M	0.0%	$15.63	42
2025-Q3	Decreased	11,194	-5.5%	$163,880	0.0%	$14.62	0
2025-Q2	Increased	11,845	+1652.2%	$183,124	0.0%	$15.10	37
2025-Q1	Decreased	676	-99.9%	$10,052	0.0%	$14.71	0
2024-Q4	Increased	500,677	+154x	$6.6M	0.0%	$12.87	44
2024-Q3	Increased	3,220	+416.0%	$45,788	0.0%	$13.89	22
2024-Q2	Decreased	624	-12.4%	$8,075	0.0%	$12.36	0
2024-Q1	Unchanged	712	0.0%	$9,890	0.0%	$13.27	0
2023-Q4	Decreased	712	-10.4%	$10,160	0.0%	$13.36	0
2023-Q3	Decreased	795	-71.4%	$12,299	0.0%	$14.48	0
2023-Q2	Increased	2,781	+37.5%	$43,690	0.0%	$14.70	27
2023-Q1	Increased	2,022	+110.6%	$33,323	0.0%	$15.31	22
2022-Q4	Unchanged	960	0.0%	$14,976	0.0%	$14.60	0
2022-Q3	Decreased	960	-74.5%	$12,451	0.0%	$12.14	0
2022-Q2	Decreased	3,764	-96.0%	$52,847	0.0%	$12.97	0
2022-Q1	Decreased	94,377	-65.4%	$1.4M	0.0%	$13.51	0
2021-Q4	Increased	273,002	+534.5%	$3.7M	0.0%	$12.71	43
2021-Q3	Increased	43,024	+2.1%	$704.7M	0.0%	$15.27	32
2021-Q2	Decreased	42,136	-83.7%	$709,149	0.0%	$15.76	0
2021-Q1	Decreased	257,890	-22.5%	$4.7M	0.0%	$17.18	0
2020-Q4	Increased	332,890	+7.0%	$6.1M	0.0%	$17.02	29
2020-Q3	Decreased	311,212	-8.8%	$5.6M	0.0%	$16.98	0
2020-Q2	Increased	341,395	+2.6%	$6.1M	0.0%	$16.95	28
2020-Q1	Increased	332,856	+4.3%	$5.1M	0.0%	$14.63	28
2019-Q4	Increased	319,019	+1.6%	$6.3M	0.0%	$18.41	28
2019-Q3	Decreased	313,955	-2.1%	$5.4M	0.0%	$16.23	0
2019-Q2	New	320,685	-	$5.7M	0.0%	$16.57	37

Other major holders of TAK: GLENVIEW CAPITAL MANAGEMENT, LLC, Capital Research Global Investors

TAK29 quarters

TAK
29 quarters